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A Systematic Methodological Review of Reported Perioperative Variables, 
Postoperative Outcomes and Hernia Recurrence from Randomised 
Controlled Trials of Elective VH Repair: Clear Definitions and Standardised 
Datasets are needed. 
 
Abstract 
Background This systematic review assesses the perioperative variables and 
post-operative outcomes reported by randomised controlled trials (RCTs) of VH 
repair. This review focuses particularly on definitions of hernia recurrence and 
techniques used for detection.  
Objective Our aim is to identify and quantify the inconsistencies in perioperative 
variable and postoperative outcome reporting, so as to justify future 
development of clear definitions of hernia recurrence and a standardised dataset 
of such variables. 
Methods The PubMed database was searched for elective VH repair RCTs 
reported January 1995 to March 2016 inclusive. Three independent reviewers 
performed article screening, and two reviewers independently extracted data. 
Hernia recurrence, recurrence rate, timing and definitions of recurrence, and 
techniques used to detect recurrence were extracted. We also assessed reported 
post-operative complications, standardised operative outcomes, patient 
reported outcomes, pre-operative CT scan hernia dimensions, intra-operative 
variables, patient co-morbidity, and hernia morphology. 
Results 31 RCTs (3367 patients) were identified. Only 6 (19.3%) defined hernia 
recurrence and methods to detect recurrence were inconsistent. Sixty-four 
different clinical outcomes were reported across the RCTs, with wound infection 
(30 trials, 96.7%), hernia recurrence (30, 96.7%), seroma (29, 93.5%), length of 
hospital stay (22, 71%) and haematoma (21, 67.7%) reported most frequently. 
Fourteen (45%), 11 (35%) and 0 trials reported CT measurements of hernia 
defect area, width and loss of domain respectively. No trial graded hernias using 
generally accepted scales. 
Conclusion VH RCTs report peri- and post-operative variables inconsistently, and 
with poor definitions. A standardised minimum dataset, including definitions of 
recurrence, is required. 
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Background 
 
In an ageing population[1] with an increasing prevalence of both obesity[2] and 
abdominal surgery, the incidence of ventral hernia (VH) is increasing[3,4].  The 
projected number of VH repairs performed in 2016 in the United States 
approaches 400,000[3]. Recurrence rates after repair are high, reaching 10 to 
40%[5],[6]. Incidence of large complex VH is also increasing and significant loss 
of domain coupled with comorbidity means these patients present the sternest 
surgical challenge[7]. Despite innovation[8–10] there is no consensus regarding 
optimal reconstructive techniques[11,12].  
 
Currently, the VH literature consists primarily of case series and large 
observational studies. This level 4 evidence[13] suggests the cause of 
postoperative complications and hernia recurrence are complex and 
multifactorial. To date, research has focussed largely on surgical 
technique[12],[14] and patient co-morbidity[15,16] with limited focus on hernia 
morphology. Although several hernia grading scales have been produced[17–
21], in an attempt to predict post-operative outcomes, few have been externally 
validated and, if so, with limited success[22–24]. Comparative trials and 
observational studies seldom define hernia recurrence and if they do, many use 
different definitions for recurrence as well as a variety of techniques to detect 
recurrence. Standardised definitions and validated datasets for VH repair studies 
would make reported data consistent, allowing for greater accuracy of trial 
comparison and meta-analysis. 
 
In this systematic review, we analysed randomised controlled trials (RCTs) of 
adult patients undergoing elective VH repair. All VH repair RCTs were included 
irrespective of the intervention and comparator groups. We analysed all 
perioperative variables and post-operative outcomes reported, paying particular 
attention to the different methods used to detect and define hernia recurrence. 
Our objective was to demonstrate the inconsistencies in variable and outcome 
reporting by RCTs and the necessity for standardised trial datasets as well as 
clear definitions of hernia recurrence and recurrence detection methods. 
 
Methods 
 
Reporting and Registration 
 
This systematic review was reported in line with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement[25]. Ethical 
permission is not required by our centre for systematic reviews of available 
primary literature. A protocol was developed and registered with PROSPERO, 
the international prospective register of systematic reviews (CRD42016043071). 
 
Inclusion and exclusion criteria 
 
Inclusion criteria for studies 
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 3 
We aimed to identify RCTs that described clinical outcomes in patients following 
VH repair between 1st January 1995 and 31st March 2016 inclusive. We excluded 
trials with less than 10 patients in an individual study arm since such data are 
likely to be weak. Only RCTs written in English were included. 
 
Target condition 
 
The target condition was surgical VH repair. All different VH morphologies were 
eligible as were all VH working group (VHWG) grades[17]. Studies describing 
femoral and/or inguinal hernias (i.e. groin hernia) were excluded. Emergency VH 
repair was excluded as was primary closure after damage control laparotomy. 
However, patients having elective VH repair after primary closure from damage 
control laparotomy were eligible as were RCTs of elective VH repair with 
bridging repair (i.e. failure to establish primary fascial closure). RCTs of 
parastomal hernia repairs were excluded. Trials with concomitant bowel 
resection were included (since this is often intended) and as long as the primary 
objective of surgical repair was VH repair. We excluded trials with either 
concomitant tumour removal or bariatric surgery. 
 
Participants 
 
Adult participants having a surgical VH repair. We excluded paediatric studies 
(defined as 18 years or less) since these are not representative of ‘typical’ CVH 
patients.  
 
Follow up 
 
We stipulated no minimum length of follow-up. 
 
Comparison 
 
There was no restriction placed on any study arm comparator (e.g. operative 
technique, mesh type, position of mesh). 
 
Search strategy and string 
 
A surgical research fellow, SGP, searched the PubMed database from 1st January 
1995 to 31st March 2016 inclusive limiting the search using the following terms: 
“adult 19+”, “human studies” and to those written in English. Our search string 
identified and combined the two following criteria to identify relevant articles: 
 
 To identify studies of VH disease including complex disease we used the 
MESH terms “hernia”, “abdominal hernia”, “umbilical hernia” and “VH” were 
used. These were combined with keywords: “abdominal wall reconstruction”; 
“herniorrhaphy”; “ventral defect” and “entero-cutaneous fistula”. 
 To identify studies of surgical techniques used for VH repair we used the 
MESH terms: “general surgery”; “reconstructive surgical procedures” and 
“surgical mesh”. This was combined with keywords: “pneumoperitoneum”, 
“botox”, “botulinium”, “two-stage”, “two step”, “staged repair”, “component 
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separation”, “transversus abdominis”, “retro-rectus”, “bridging”, “bridge 
repair”, “silo”, “open” and “laparoscopic”. 
 
Our complete search string is shown in online resource 1.  
 
Citation management and screening 
 
SGP stored identified citations in an Excel spreadsheet (Microsoft Excel for Mac 
2011 Version 14.5.9, Microsoft Corporation, Washington, USA), up-loading these 
subsequently into a reference manager able to access online original articles 
directly (Mendeley Desktop Version 1.17 for Windows XP and Mac OS X, London, 
UK). After the search filters were applied and duplicates were excluded, the 
citations were divided into two equal groups. The titles of the first-half of the 
citations were screened by SGP and the second-half by CW. The researchers 
screened for comparative studies of VH disease. They discarded articles that 
were ‘clearly unsuitable’ for the review (e.g. subject not VH) and retained any 
regarded as ‘uncertain’ or ‘definitely possible’. These two latter groups were 
combined and researchers, SGP, CW and RB, then independently screened the 
titles and abstracts of the ‘uncertain’ and ‘definitely possible’ results with the aim 
of identifying all comparative studies. Any discrepancies were settled by face-to-
face discussion amongst the three researchers. A third hand search of the full 
text by SGP, CW and RB, then divided the selected comparative studies into 
respective methodological designs; case-control studies, cohort studies and 
RCTs. Any article where uncertainty persisted was discussed with senior 
members, AW and SH, face-to-face. An exclusion log was kept at all stages. The 
PRISMA diagram (fig 1.) shows the flow of article selection.  
 
Data extraction 
 
SGP and JB extracted data independently from all RCTs selected for the review, 
which were cross-checked subsequently face-to-face. Data were entered by the 
researchers into an Excel datasheet and categorised into broad groups as 
follows: study design; hernia morphology; pre-operative patient factors 
including comorbidities; intraoperative variables and clinical outcomes, 
including complication rates and hernia recurrence.  
 
Study demographics and risk of bias 
 
Information extracted for RCT study design included: the study setting (multi-
centre vs. single centre), the country of publication, the date of publication and 
the number of patients in each study arm. Researchers, SGP and JB, used the 
Cochrane Collaboration’s tool to assess the risk of bias[26]. Any differences in 
opinion were discussed face-to-face and settled by discussion with senior 
authors if required. 
 
Hernia morphology 
 
For hernia morphology, we intended to record dimensions of the hernia defect, 
including area, loss of domain, the ventral hernia working group (VHWG) 
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grade[17] and the CDC wound classification[27]. We recorded whether the study 
included patients with either primary or incisional VHs, or both, and if so the 
proportion of these two hernia types. However, we anticipated that many trials 
would not report these details of hernia morphology and grade, and recorded 
when these items were not reported. Similarly, we recorded the number of 
previous attempts at hernia repair where documented. We noted prior surgical 
site infection in patients undergoing repair since this is known to predispose to 
subsequent recurrence[15]. 
 
Pre-operative patient characteristics and co-morbidities 
 
Baseline patient characteristics extracted were mean patient age and the 
proportion of male to females. Comorbidity data included the mean and standard 
deviation of body mass index (BMI), the proportion of patients with chronic 
obstructive pulmonary disease (COPD), diabetes, steroid use, and the proportion 
of each American Society of Anaesthesiologists (ASA) grade (and mean ASA 
grade) in each study group. Proportion by smoking status, arteriopath status 
(previous diagnosis of ischaemic heart disease (IHD), peripheral vascular disease 
(PVD), cerebrovascular accidents (CVAs)) and a diagnosis of benign prostatic 
hypertrophy (BPH) were also noted. 
 
Intra-operative variables 
 
We recorded the mode of surgery used (e.g. laparoscopic or open), the type of 
mesh where used, the anatomical layer within the abdominal wall into which the 
mesh was implanted (i.e. intraperitoneal, pre-peritoneal, retro-rectus, inlay or 
onlay), operative duration, intra-operative blood loss, and the experience of the 
principal surgeon where documented. 
 
Reported Clinical Outcomes 
 
Hernia recurrence 
 
Our outcomes of primary interest were; hernia recurrence, the post-operative 
recurrence rates, the timing of recurrence, the definitions for VH recurrence 
used, and the test method(s) used to diagnose recurrence (for example clinical 
examination, CT scan, US scan) were recorded. These data were analysed to 
investigate whether the method used to detect recurrence influenced recurrence 
rate. As we were aware of no generally accepted imaging definition of VH 
recurrence, we anticipated considerable inter-observer variability for reporting 
recurrence.  
 
We did not pre-specify the definition of post-operative hernia recurrence. We did 
not restrict by timing of recurrence, the definitions for VH recurrence used, or 
the test method(s) used to diagnose recurrence.  
 
Secondary outcomes 
 
Post-operative complications 
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All post-operative complications described were recorded. Complications were 
grouped into intraoperative, early postoperative, late post-operative, and 
general or standardised outcomes. Early postoperative complications were sub-
grouped into local wound complications (wound infection, seroma formation, 
wound dehiscence, skin necrosis) and systemic complications (hospital acquired 
pneumonia, myocardial infarction, pulmonary embolism). Early post-operative 
complications were defined as those occurring within 30 days of surgery and late 
post-operative complications as those occurring thereafter. Late complications 
were extracted for the timespan presented in the paper.  
 
Standardised outcomes 
 
Where reported, we recorded all standardised post-operative outcome measures 
used. We anticipated that RCTs would use a variety of outcome measures such as 
length of hospital stay, 30-day re-operation rate and 30-day re-admission rate. If 
trial complications were measured using a standardised post-operative 
complication scale, the value was recorded.  
 
Patient reported outcome measures 
 
We foresaw that some trials may use standardised patient reported outcome 
measures (PROMs) to measure operative success. These may include visual 
analogue scales for pain or overall health status. They may also report the time 
to first bowel movement or the time taken to return to normal activities. All such 
outcomes were recorded, along with the timing of the assessment. 
 
Results 
 
Search results 
 
Our initial search retrieved 15771 results (fig 1.). After applying search filters 
[studies published between 1st January 1995 to 31st March 2016, human trials 
only, participants aged ≥19, studies written in English], we excluded 9286 
studies, resulting in 6485 papers for our initial review. After screening the 
citation titles, we ultimately categorised 874 studies as ‘definitely possible’ or 
‘uncertain’. This fell to 174 comparative studies after title and abstract screening. 
The full text of all 174 articles was assessed for details of study methodology. 
This identified 31 RCTs included in the present systematic review.  
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Figure 1. PRISMA diagram showing selection of RCTs for this review 
 
 
Study demographics 
 
Study demographics and design characteristics are shown in Table 1. The 31 
RCTs included 3,367 patients with a mean of 109 patients, range 24 to 337. One 
study[28] appears twice since it divided patients into simple and complex hernia 
groups, creating two individual trials (suture vs mesh repair and prosthetic mesh 
vs auto-dermal graft repair). Five RCTs were carried out in both the 
Netherlands[29–33] and Spain[34–38]. Thirteen RCTs were multi-centre and 18 
were single centre. Over the past 20 years the number of RCTs performed 
increased, with 8 published between 1995 to 2005 versus 23 published from 
2005 to 2016. There were 3 groups where RCTs compared the same 
interventions: Eleven studies compared laparoscopic versus open repair; 5 
studies[28,30,36,39,40] compared suture versus mesh repair and 3 
studies[37,41,42] compared tack versus suture mesh fixation in laparoscopic VH 
repair.  
Records	identified	through	
database	screening	
n	=	15771
Citation	title	screening:	studies	‘clearly	
unsuitable’	excluded n	=	5611	
Full	text	articles	excluded	n	=	143
• Non-randomised	design	n	=	134
• Emergency	hernia	repairs	included					n	=	2
• No	English	translation	n	=	3
• Protocol	papers	n	=	2
• Incorrect	study	design	n	=	2
Citation	title	&	abstract	screening:	studies	
‘clearly	unsuitable’	excluded	n=	700
Filters	applied	and	duplicates	
removed
n	=	6485
Studies	‘uncertain’	or	‘definitely	
possible’	remain
n	=	874
Full	text	comparative	studies	
assessed	for	eligibility
n	=	174
Randomised	controlled	trials	
included	in	qualitative	synthesis	
n	=		31
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Table 1. Demographic and characteristics of the 31 RCTs included in the 
Systematic Review. 
 
Included Studies - Demographics 
 Characteristic Subgroup No. of RCTs 
   -Country of Publication Netherlands[29–33] Spain[34–38] 5 
 
India[41–43] Eygpt[44–46] 3 
 
Pakistan[40],[47] Turkey[39],[48] Italy[49,50]Germany [28],[51] 2 
 
Sweden[52] USA[53] Australia(54) Lithuania[55] France[56] 
Belgium[57] Denmark[58] 1 
-Multi vs Single-centre Multi centre[28-30],[32-34],[40],[49],[51-53],[57-58] 13 
 
Single centre[31],[35-39],[41-46],[48-50],[54-56] 18 
-Year of Publication 1995-2005[28],[30],[32],[35-36],[39],[46] 7 
 
2006-2016[29],[31],[33-34],[37-38],[40-45],[47-58] 24 
Included Studies 
  Characteristic Subgroup No. of RCTs 
-Trial Groups Laparoscopic vs. Open[29],[34-35],[43],[47-50],[52-54] 11 
 
Open mesh vs. suture[28],[30],[36],[39-40] 5 
 
Laparoscopic mesh fixation; Tacks vs. Sutures[31],[37],[41-42] 3 
 
 Open VH repair:  
 
 
Onlay vs. Sublay[44],[55] 2 
 
Light weight vs. Heavy weight mesh[32] 1 
 
Medium weight vs. Medium weight mesh[51] 1 
 
Autograft vs. Prosthetic mesh*[28*] 1 
 
Component separation vs. Prosthetic mesh[33] 1 
 
Onlay vs. Underlay[45] 1 
 
Intraperitoneal vs. Onlay [bridging][46] 1 
 
Ventralex patch vs Biomesh composite mesh[56] 1 
 
 Laparoscopic VH repair: 
  Double crown tack vs. suture and tack mesh fixation[31],[57] 2 
 Double crown tack vs. fibrin sealant mesh fixation[58] 1 
 
Light weight mesh vs. Medium weight mesh[38] 1 
 
Total 32 
 
*Large hernias from Korenkov et al. (a suture vs. mesh RCT) were 
analysed as a separate category. This makes this total 32 rather than 
31. 
 
-Hernia type Primary hernias only[36],[39-40],[44-45],[47] 6 
 Incisional hernias only[28-30],[32-34],[38],[46],[49-53],[55] 14 
 Primary and incisional hernias[31],[35],[37],[41-43],[48],[54],[56-58] 11 
-Primary outcomes Hernia recurrence[28],[49],[54],[56] 4 
 
Quality of life/ Health questionnaires[32],[34],[51-52] 4 
 
Pain [measured using visual analogue scores][29],[31],[57],[58] 4 
 
Pain and hernia recurrence [two primary outcomes][38] 1 
 
Mesh shrinkage[37] 1 
 
Total complications rates[53] 1 
 
Unclear[30],[33],[35-36],[39-48],[50],[55] 16 
-Risk of Bias: Cochrane 
Collaboration’s tool 
High risk of bias[28-50],[52-58] 30 
 Low risk of bias[51] 1 
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias 
item presented as percentages across all included studies. 
 
 
Risk of bias and study design 
 
Thirty RCTs were assessed as at high risk of bias with just one[51] considered at 
low risk. Figure 2 shows that this high level of bias is mostly due to the failed 
blinding of trial participants, personnel (surgeons) and outpatient assessors. 
Only two trials[32],[51] achieved blinding for both these criteria.  
 
Hernia morphology 
 
Twenty-three of 30 (76.6%) RCTs used hernia dimensions as an inclusion 
criteria and one RCT[28] divided hernias into simple and complex categories 
using a 10cm defect width cutpoint. Seven trials had no selection criteria that 
used hernia dimension. The exact nature of dimension inclusion criteria varied 
across trials, ranging from hernias with a width of less than 4cm[39], to hernias 
with a width of greater than 10cm[28,46]. Fourteen trials (45.2%) recorded the 
average defect surface area, which ranged from 3.4cm2 to 141.2cm2, with a mean 
of 43.1cm2. Eleven trials (35.5%) recorded the average or median hernia width 
within each comparison group, which ranged from 3.6cm to 17cm with a mean of 
7.5cm. None of the RCTs reported loss of domain or used loss of domain for 
patient selection (Table 2.). 
 
As anticipated, no RCT recorded either VHWG grade or CDC wound classification 
of included hernias. Indeed, no RCT used a VH grading scale of any description. 
Six trials (19.3%) included primary VHs only, 14 trials (45.2%) included 
incisional hernias only, and 11 trials (35.5%) included both primary and 
incisional hernias. Ten of these 11 trials, including both primary and incisional 
VHs, reported the proportion of primary to incisional hernias, with a mean of 32 
primary to 41 incisional hernias (range 31:7[58] to 18:65[57]). Seven of the 25 
trials (28%) analysing incisional hernias included the ratio of primary incisional 
hernias to recurrent incisional hernias (mean of 84.1 primary to 28.3 incisional 
hernias, range 160:3[49] to 24:30[28]). Only two trials [30,47] reported the 
number of patients with previous ventral wound infection. 
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Table 2. Summarising the hernia morphology data reported. 
Hernia dimension No. of RCTs reporting variable 
Average hernia defect surface area 14[30-31],[35],[37-38],[41],[43],[50],[52-57] 
Average hernia defect width 11[28,29],[32-34],[38],[40],[44],[49-50],[52] 
Loss of Domain 0 
 
Pre-operative patient characteristics and co-morbidities 
 
Table 3 summarises the patient characteristics and comorbidities reported.  
The pre-operative patient characteristics and comorbidities reported differed 
between trials. While many reported basic patient demographics of age, gender 
and BMI, few went beyond this to report patient comorbidities, including 
smoking status, diabetic status and steroid use.  
 
Table 3. Preoperative patient characteristics and comorbidities reported.  
Patient characteristic/comorbidities No. of RCTs reporting variable 
Age [mean] 30[28-39],[41-58] 
Gender [male/female ratio] 29[28-39],[41-50],[52-58] 
Obesity [as a ratio >/< 35 or mean [SD]] 23[28-34],[37-38],[41-45],[48-50],[51-53],[55-58] 
No. patients ASA 3 10[29],[31],[36-37],[39],[45],[49],[51-53] 
COPD 8[28],[34],[38],[43],[45],[51-53] 
Smoking status 8[28],[30],[45],[51-53],[56-57] 
No. patients with Diabetes 7[34],[38],[44],[51-53],[56] 
No. patients ASA 1 7[29],[31],[45],[49],[51-53] 
No. patients ASA 2 7[29],[31],[45],[49],[51-53] 
SF-36 QoL questionnaire[59] 3[32],[51],[52] 
No. patients using steroids 3[28],[51],[53] 
No. of arteriopaths [IHD/PVD/CVA] 3[28],[44],[52] 
No. patients ASA 4 3[29],[49],[51] 
Average ASA score 2[34],[55] 
Liver cirrhosis / Childs-Pugh A 1[44] 
SF-12 QoL questionnaire[59] 1[56] 
 
Intra-operative variables 
 
Table 4 shows that intraoperative variables were reported with increased 
frequency compared to pre-operative variables and patient comorbidities. Mode 
of surgery, type of mesh implanted (prosthetic, composite, biosynthetic or 
biologic) and anatomical layer were recorded in all 31 RCTs. Operation duration, 
intra-operative blood loss and the experience of the principal operating surgeon 
were all reported less frequently. 
 
Table 4. Intra-operative variables reported.  
Intra-operative variable No. of RCTs reporting variable 
Mode of Surgery [laparoscopic/open] 31[28-58] 
Category of mesh used 31[28-58] 
Anatomical layer of mesh placement 31[28-58] 
Duration of operation 27[28-31],[33-45],[48-50],[52-58] 
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Experience of the principal surgeon 14[29],[31],[33-34],[36],[46-47],[49],[52-55],[57-58] 
Intra-operative blood loss 3[29],[33],[43] 
 
Clinical outcomes 
 
Sixty-four different clinical outcomes were reported overall, with little 
consistency between trials, even when reporting similar intervention groups and 
primary outcomes. Indeed, 16 (51.6%) RCTs stated no primary outcome 
explicitly (Table 1). Of the 15 RCTs (48.4%) stating a primary outcome; 
4[28,49,54,56] used hernia recurrence and 4[32,34,51,52] employed quality of 
life. Three trials[32],[51,52] used the SF-36 questionnaire[59] and 1 trial[34] 
used the EQ-5D questionnaire[60]. Four trials[29,31,57,58] used pain as their 
primary outcome, assessed via visual analogue scales (VASs). One trial stated 
both pain and recurrence as two separate primary outcomes, with no statistical 
accounting for co-primary outcomes[38]. The remaining two trials used mesh 
shrinkage[37] or standardised complication rates[53] as their primary outcomes 
respectively. Multiple different primary outcomes led to many different clinical 
and patient reported outcomes (as shown in online resource 2).  
 
Length of follow-up was reported in all studies and averaged 24.5 months (range 
1 month to 64 months). Fifteen of 31 (48%) trials had follow-up of at least 24 
months. One trial[52] did not report hernia recurrence rate. Of the 30 trials 
reporting hernia recurrence, 1 RCT[36] reported recurrence at 5 years post 
repair, 4 RCTs[29-30],[41],[56] reported recurrence at 3 years, 15 RCTs at 2 
years, 13 RCTs at 1 year, 5 RCTs[37],[41],[43],[50-51] at 6 months and 1 
RCT[34] at 3 months. Six (20%) of 30 RCTs defined recurrence: definitions are 
shown in table 5. Only three trials used the same definition. Eight (29%) of 30 
trials did not specify the method used to detect recurrence. Twelve trials (43%) 
used clinical examination alone to detect recurrence. Ten (33%) trials used 
imaging if recurrence was in doubt, or to confirm a recurrence suspected 
clinically. Five (50%) of these 10 trials[29,31,33,43,57] used either CT or USS to 
detect recurrence, 3 (30%) trials[30,42,58] used USS alone and 2 (20%) 
trials[38,46] used CT alone. Recurrence rates increased when imaging was used. 
Trials using clinical examination had a 4% median recurrence rate whereas trials 
using USS or CT, USS alone, or CT alone had median recurrence rates of 7%, 9% 
and 7% respectively. Trials that did not specify test methods for recurrence had 
a mean re-herniation rate of 7%. The method used to detect hernia recurrence 
did not depend on the size or type of hernia included in the trial (as shown in 
online resource 3). Patient reported outcomes used the SF-36[59], SF-12[59], 
EQ-5D[60], and GIQL[62] questionnaires as well as VASs, to assess pain and 
overall health status. These were also carried out at varying time intervals. The 
Calvien-Dindo[61] scale for post-operative complications was used in 9 of the 
trials to classify complication severity. 
 
Table 5. Six definitions of hernia recurrence encountered in the systematic 
review. 
Reference: Definition 
Arroyo et al.[36] 
(2001) 
‘the presence of a defect on the central part of the midline aponeurosis 
around the umbilicus, where the operation had been performed 
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Bensaadi et al.[56] 
(2014) 
Lal et al.[40] 
(2012) 
previously.’ 
‘a defect of the midline aponeurosis around the umbilicus at the site 
where the operation was performed.’ 
‘the presence of a defect on the central part of the midline aponeurosis 
where the operation had been performed previously.’ 
Luijendijk et al.[30] 
(2000) 
‘any fascial defect that was palable or detected by ultrasound 
examination and was located within 7cm of the site of hernia repair.’ 
Pring et al.[54] 
(2008) 
‘a clinically detectable defect, associated with the protrusion of viscera 
on straining’. 
Muysoms et al.[57] 
(2013) 
‘Patients were considered free from recurrence if at clinical 
examination, no hernia was felt in an upright position during valsalva 
manoeuver.’ 
 
Discussion 
 
This systematic review has analysed the reported perioperative variables and 
postoperative outcomes from randomised controlled trials of elective VH repair, 
performed over the last twenty years. Important findings include the general 
absence of: a standardised pre-operative patient variable dataset; a universally 
accepted definition of recurrence; standardised test methods to detect 
recurrence; standardised assessment times for the key primary and secondary 
outcomes, and standardised evaluation tools for post-operative pain and quality 
of life. This lack of standardisation limits the validity of trial comparisons made 
by meta-analyses and comparison of trials by practicing surgeons. Our review 
provides evidence-based justification for urgent investment in a core 
perioperative and clinical outcome dataset applicable to trials of VH surgery. 
This should be developed and validated with key stakeholders to improve the 
quality of outcome reporting in this rapidly developing field. A group such as 
COMET needs identification and encouragement to help develop and endorse 
this work[63]. 
 
As VH research evolves, academics are searching increasingly for outcome 
predictors. Potentially reliable predictors can be identified from the primary 
literature only when they are reported.  Our review has found that randomised 
controlled trials are focusing on surgical technique and failing to report variables 
that would normally be regarded as important predictors. For example, many 
pre-operative patient comorbidities and, in particular, measures of hernia 
morphology (e.g. hernia width and area) were omitted from most reports. Loss 
of domain was not reported by any trial. Because current evidence is 
contradictory, with some studies suggesting that hernia width does correlate 
with recurrence[64] whereas others do not[65,66], future trials need to report 
apparently important predictors to facilitate subsequent analysis. Investigators 
should also grade hernias using appropriate scales, for example the VHWG 
scale[17] and the CDC wound classification scale[27] as these scales themselves 
may prove to be outcome predictors. Our review demonstrates that a trial 
dataset with multiple pre-operative patient variables (diabetes, COPD, BMI, 
hernia grade etc), including pre-operative CT scan dimensions (hernia defect 
area, hernia width, loss of domain etc) and intra-operative variables (operation 
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time, anatomical plane of mesh insertion, reconstructive technique etc) is 
required. 
 
While 8 of the 30 trials (26.7%) reporting hernia recurrence didn’t even define 
how recurrence was detected, the remaining trials used differing recurrence 
detection methods ranging from undefined clinical examination to undefined 
imaging methods. This introduces bias depending on the differing examination 
and imaging methods used. There was much variation in the timing of 
assessment for hernia recurrence. This observed lack of consensus regarding 
assessment timing, test methods for recurrence, and definitions of recurrence 
limits data availability and consistency, and impairs meta-analysis. To achieve 
standardisation a clear definition of VH recurrence is required. Imaging is likely 
the most precise method with which to determine recurrence, but a radiological 
definition of recurrence is required that incorporates measures of clinically 
important and unimportant reherniation. Currently, there is considerable 
variability in recurrence reporting for CT scans[67]. Our review suggests that the 
use of imaging does increase reported recurrence rates, which would be 
anticipated since subclinical recurrences will be identified.  
 
RCT dataset designers should also consult the recommendations made by 
Muysoms et al. following a consensus meeting in Palmero, Italy in 2012[68]. This 
work gives detailed advice on how to carry out statistically sound research 
(interventional studies, observational studies, systematic review, and meta-
analysis) in abdominal wall repair. Of particular relevance, this article advises 
using the EuraHS definition for hernia recurrence[69]; “a protrusion of the 
contents of the abdominal cavity or preperitoneal fat through a defect in the 
abdominal wall at the site of a previous repair of an abdominal wall hernia”, which 
we support, although (as stated above) a future definition of recurrence that 
includes radiological detection maybe more accurate but requires development. 
Muysoms et al. recommend using the EHS hernias classifications scales and 
measuring post-operative complications using the Clavien-Dindo classification 
system but do not define or list any other peri-operative or post-operative 
outcome variables that sound be measured. Importantly, they do allow for 
variability in the method used for recurrence detection and the time to 
outpatient assessment, which we feel this should be standardised, especially in 
RCTs. To standardise trial outcomes, a dataset with clear definitions and follow 
up assessment times is warranted.  
 
A standardised dataset should include tools to assess chronic pain and quality of 
life (QoL). When comparing different surgical techniques, chronic pain and QoL 
are important patient-centred endpoints, as patients frequently place more 
emphasis on these outcomes than the operative surgeon. In this review, simple 
visual analogue scales were used commonly to assess pain. However, these 
analogue scales, and the timings of assessment were not standardised. A future 
dataset must standardise pain assessment. QoL was measured using many 
different questionnaires (SF-36[59], SF-12[59], EuroQoL[60]  and GIQL[62]). 
These questionnaires are commonly used and they allow for health economic 
analysis across different disease states. However, they are not disease specific, 
and may miss important patient reported outcomes specific to hernia surgery. 
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Due to the unique set of complications arising from VH surgery, the importance 
of chronic pain and QoL, a hernia-specific patient reported outcome assessment 
tool, such as the Carolinas Comfort Scale[70] or the EuraHS-QoL 
questionnaire[69], should be used.  
 
When constructing a VH perioperative variable and postoperative outcome 
dataset for randomised control trials, workers should also consult the VH 
databases currently being used in America[71], Europe[69], Denmark[72] and 
Spain[73]. These databases collect data prospectively from large cohorts of 
patients and will generate sizeable observational studies. These databases have 
been constructed by VH experts with multiple peri-operative and post-operative 
data-points, many of which should be included in an RCT dataset. 
 
As well as focusing on standardised definitions and datasets, academic surgeons 
carrying out RCTs should make concerted efforts to reduce trial bias. Thirty of 
the 31 included trials were assessed as at high risk of bias. Many of the included 
trials performed poorly in 3 out of the 7 domains of the Cochrane Collaboration’s 
tool for risk of bias[26]. Many trials failed to specify how participant group 
allocation was concealed, failed to blind participant and surgeon from the 
allocated treatment, and there was no blinding in the outpatient assessment 
clinic. Traditionally, surgical trials are usually at high risk of bias due to the 
impossibility of blinding the primary surgeon. However, if visible skin changes to 
the participant do not differ between the treatment groups [e.g. open VH repair 
with onlay vs. sublay mesh], it is possible to blind both the participant and an 
independent assessor. In addition, concealment of treatment allocation should 
follow the standards set by the Cochrane Collaboration. In surgery, the allocated 
treatment should only be revealed to an independent surgeon after the 
participant is under general anaesthetic and after the participant has been 
consented to take part in the trial and both possible treatments.   
 
Further bias can arise in RCTs due to commercial funding and readers should be 
aware of this. We accept there are difficulties in achieving non-commercial 
funding for RCTs in hernia research and that without proper funding scrupulous 
methodology can be challenging due to the high work load. Eight out of 31 one of 
the trials received commercial funding[31,32],[37],[51],[54],[56–58], one trial 
received non-commercial funding[53] and one trial received both commercial 
and non-commercial funding[52]. In the remaining 21 trials the funding method 
was not specified. The practical difficulty of obtaining non-commercial funding 
can only be addressed by researchers, who whilst applying for funding must 
clearly explain the technical difficulties faced by reconstructive surgeons and the 
high prevalence of morbidity suffered by patients after hernia repair; namely 
chronic pain and recurrence. If researchers face difficulties with funding or 
carryout research with commercial funding, little can be done apart from 
carrying out research to highest possible standards. We note that any data is 
better than no data, as supported by Lilford et al[74].  
 
Conclusion 
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So far systematic reviews of elective VH RCTs have focused on comparing the 
outcomes of open versus laparoscopic VH repair[75],[76],[77]. This review is the 
first to assesses the methodology of VH RCTs. The results show that the 
perioperative variables and postoperative outcomes reported by RCTs of VH 
repair lack definition and consistency. To solve this, a defined minimum dataset 
of variables and outcomes is required. Since operative success is determined by 
the presence or absence of hernia recurrence, recurrence is therefore the prime 
outcome and requires standard clinical and radiological definitions, together 
with a minimum period of follow-up. For a clinical definition, we recommend 
using the European definition for hernia recurrence[69], and that a radiological 
definition requires development. Such measures will standardise and therefore 
improve outcome reporting in this rapidly expanding and important field, 
increasing data homogeneity and the value of subsequent meta-analysis.  
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A Systematic Methodological Review of Reported Perioperative Variables, 
Postoperative Outcomes and Hernia Recurrence from Randomised 
Controlled Trials of Elective VH Repair: Clear Definitions and Standardised 
Datasets are needed. 
 
Abstract 
Background This systematic review assesses the perioperative variables and 
post-operative outcomes reported by randomised controlled trials (RCTs) of VH 
repair. This review focuses particularly on definitions of hernia recurrence and 
techniques used for detection.  
Objective Our aim is to identify and quantify the inconsistencies in perioperative 
variable and postoperative outcome reporting, so as to justify future 
development of clear definitions of hernia recurrence and a standardised dataset 
of such variables. 
Methods The PubMed database was searched for elective VH repair RCTs 
reported January 1995 to March 2016 inclusive. Three independent reviewers 
performed article screening, and two reviewers independently extracted data. 
Hernia recurrence, recurrence rate, timing and definitions of recurrence, and 
techniques used to detect recurrence were extracted. We also assessed reported 
post-operative complications, standardised operative outcomes, patient 
reported outcomes, pre-operative CT scan hernia dimensions, intra-operative 
variables, patient co-morbidity, and hernia morphology. 
Results 31 RCTs (3367 patients) were identified. Only 6 (19.3%) defined hernia 
recurrence and methods to detect recurrence were inconsistent. Sixty-four 
different clinical outcomes were reported across the RCTs, with wound infection 
(30 trials, 96.7%), hernia recurrence (30, 96.7%), seroma (29, 93.5%), length of 
hospital stay (22, 71%) and haematoma (21, 67.7%) reported most frequently. 
Fourteen (45%), 11 (35%) and 0 trials reported CT measurements of hernia 
defect area, width and loss of domain respectively. No trial graded hernias using 
generally accepted scales. 
Conclusion VH RCTs report peri- and post-operative variables inconsistently, and 
with poor definitions. A standardised minimum dataset, including definitions of 
recurrence, is required. 
 
  
Blinded Manuscript
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Background 
 
In an ageing population[1] with an increasing prevalence of both obesity[2] and 
abdominal surgery, the incidence of ventral hernia (VH) is increasing[3,4].  The 
projected number of VH repairs performed in 2016 in the United States 
approaches 400,000[3]. Recurrence rates after repair are high, reaching 10 to 
40%[5],[6]. Incidence of large complex VH is also increasing and significant loss 
of domain coupled with comorbidity means these patients present the sternest 
surgical challenge[7]. Despite innovation[8–10] there is no consensus regarding 
optimal reconstructive techniques[11,12].  
 
Currently, the VH literature consists primarily of case series and large 
observational studies. This level 4 evidence[13] suggests the cause of 
postoperative complications and hernia recurrence are complex and 
multifactorial. To date, research has focussed largely on surgical 
technique[12],[14] and patient co-morbidity[15,16] with limited focus on hernia 
morphology. Although several hernia grading scales have been produced[17–
21], in an attempt to predict post-operative outcomes, few have been externally 
validated and, if so, with limited success[22–24]. Comparative trials and 
observational studies seldom define hernia recurrence and if they do, many use 
different definitions for recurrence as well as a variety of techniques to detect 
recurrence. Standardised definitions and validated datasets for VH repair studies 
would make reported data consistent, allowing for greater accuracy of trial 
comparison and meta-analysis. 
 
In this systematic review, we analysed randomised controlled trials (RCTs) of 
adult patients undergoing elective VH repair. All VH repair RCTs were included 
irrespective of the intervention and comparator groups. We analysed all 
perioperative variables and post-operative outcomes reported, paying particular 
attention to the different methods used to detect and define hernia recurrence. 
Our objective was to demonstrate the inconsistencies in variable and outcome 
reporting by RCTs and the necessity for standardised trial datasets as well as 
clear definitions of hernia recurrence and recurrence detection methods. 
Currently, rigorous level 1 research is relatively lacking. We anticipated that 
RCTs of VH repair use a variety of comparison groups, report different 
preoperative and intraoperative variables, and study multiple clinical outcomes. 
Consequently, we hypothesised that the published RCTs’ report highly 
heterogeneous data. Our objective was to investigate this hypothesis by 
systematic review, paying particular attention to the definitions and methods 
used to report hernia recurrence. 
 
Methods 
 
Reporting and Registration 
 
This systematic review was reported in line with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement[25]. Ethical 
permission is not required by our centre for systematic reviews of available 
Commented [SP1]: PICOS added 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 3 
primary literature. A protocol was developed and registered with PROSPERO, 
the international prospective register of systematic reviews (CRD42016043071). 
 
Inclusion and exclusion criteria 
 
Inclusion criteria for studies 
 
We aimed to identify RCTs that described clinical outcomes in patients following 
VH repair between 1st January 1995 and 31st March 2016 inclusive. We excluded 
trials with less than 10 patients in an individual study arm since such data are 
likely to be weak. Only RCTs written in English were included. 
 
Target condition 
 
The target condition was surgical VH repair. All different VH morphologies were 
eligible as were all VH working group (VHWG) grades[17]. Studies describing 
femoral and/or inguinal hernias (i.e. groin hernia) were excluded. Emergency VH 
repair was excluded as was primary closure after damage control laparotomy. 
However, patients having elective VH repair after primary closure from damage 
control laparotomy were eligible as were RCTs of elective VH repair with 
bridging repair (i.e. failure to establish primary fascial closure). RCTs of 
parastomal hernia repairs were excluded. Trials with concomitant bowel 
resection were included (since this is often intended) and as long as the primary 
objective of surgical repair was VH repair. We excluded trials with either 
concomitant tumour removal or bariatric surgery. 
 
Participants 
 
Adult participants having a surgical VH repair. We excluded paediatric studies 
(defined as 18 years or less) since these are not representative of ‘typical’ CVH 
patients.  
 
Follow up 
 
We stipulated no minimum length of follow-up. 
 
Comparison 
 
There was no restriction placed on any study arm comparator (e.g. operative 
technique, mesh type, position of mesh). 
 
Search strategy and string 
 
A surgical research fellow, SGP, searched the PubMed database from 1st January 
1995 to 31st March 2016 inclusive limiting the search using the following terms: 
“adult 19+”, “human studies” and to those written in English. Our search string 
identified and combined the two following criteria to identify relevant articles: 
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 To identify studies of VH disease including complex disease we used the 
MESH terms “hernia”, “abdominal hernia”, “umbilical hernia” and “VH” were 
used. These were combined with keywords: “abdominal wall reconstruction”; 
“herniorrhaphy”; “ventral defect” and “entero-cutaneous fistula”. 
 To identify studies of surgical techniques used for VH repair we used the 
MESH terms: “general surgery”; “reconstructive surgical procedures” and 
“surgical mesh”. This was combined with keywords: “pneumoperitoneum”, 
“botox”, “botulinium”, “two-stage”, “two step”, “staged repair”, “component 
separation”, “transversus abdominis”, “retro-rectus”, “bridging”, “bridge 
repair”, “silo”, “open” and “laparoscopic”. 
 
Our complete search string is shown in online resource 1.  
 
Citation management and screening 
 
SGP stored identified citations in an Excel spreadsheet (Microsoft Excel for Mac 
2011 Version 14.5.9, Microsoft Corporation, Washington, USA), up-loading these 
subsequently into a reference manager able to access online original articles 
directly (Mendeley Desktop Version 1.17 for Windows XP and Mac OS X, London, 
UK). After the search filters were applied and duplicates were excluded, the 
citations were divided into two equal groups. The titles of the first-half of the 
citations were screened by SGP and the second-half by CW. The researchers 
screened for comparative studies of VH disease. They discarded articles that 
were ‘clearly unsuitable’ for the review (e.g. subject not VH) and retained any 
regarded as ‘uncertain’ or ‘definitely possible’. These two latter groups were 
combined and researchers, SGP, CW and RB, then independently screened the 
titles and abstracts of the ‘uncertain’ and ‘definitely possible’ results with the aim 
of identifying all comparative studies. Any discrepancies were settled by face-to-
face discussion amongst the three researchers. A third hand search of the full 
text by SGP, CW and RB, then divided the selected comparative studies into 
respective methodological designs; case-control studies, cohort studies and 
RCTs. Any article where uncertainty persisted was discussed with senior 
members, AW and SH, face-to-face. An exclusion log was kept at all stages. The 
PRISMA diagram (fig 1.) shows the flow of article selection.  
 
Data extraction 
 
SGP and JB extracted data independently from all RCTs selected for the review, 
which were cross-checked subsequently face-to-face. Data were entered by the 
researchers into an Excel datasheet and categorised into broad groups as 
follows: study design; hernia morphology; pre-operative patient factors 
including comorbidities; intraoperative variables and clinical outcomes, 
including complication rates and hernia recurrence.  
 
Study demographics and risk of bias 
 
Information extracted for RCT study design included: the study setting (multi-
centre vs. single centre), the country of publication, the date of publication and 
the number of patients in each study arm. Researchers, SGP and JB, used the 
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 5 
Cochrane Collaboration’s tool to assess the risk of bias[26]. Any differences in 
opinion were discussed face-to-face and settled by discussion with senior 
authors if required. 
 
Hernia morphology 
 
For hernia morphology, we intended to record dimensions of the hernia defect, 
including area, loss of domain, the ventral hernia working group (VHWG) 
grade[17] and the CDC wound classification[27]. We recorded whether the study 
included patients with either primary or incisional VHs, or both, and if so the 
proportion of these two hernia types. However, we anticipated that many trials 
would not report these details of hernia morphology and grade, and recorded 
when these items were not reported. Similarly, we recorded the number of 
previous attempts at hernia repair where documented. We noted prior surgical 
site infection in patients undergoing repair since this is known to predispose to 
subsequent recurrence[15]. 
 
Pre-operative patient characteristics and co-morbidities 
 
Baseline patient characteristics extracted were mean patient age and the 
proportion of male to females. Comorbidity data included the mean and standard 
deviation of body mass index (BMI), the proportion of patients with chronic 
obstructive pulmonary disease (COPD), diabetes, steroid use, and the proportion 
of each American Society of Anaesthesiologists (ASA) grade (and mean ASA 
grade) in each study group. Proportion by smoking status, arteriopath status 
(previous diagnosis of ischaemic heart disease (IHD), peripheral vascular disease 
(PVD), cerebrovascular accidents (CVAs)) and a diagnosis of benign prostatic 
hypertrophy (BPH) were also noted. 
 
Intra-operative variables 
 
We recorded the mode of surgery used (e.g. laparoscopic or open), the type of 
mesh where used, the anatomical layer within the abdominal wall into which the 
mesh was implanted (i.e. intraperitoneal, pre-peritoneal, retro-rectus, inlay or 
onlay), operative duration, intra-operative blood loss, and the experience of the 
principal surgeon where documented. 
 
Reported Clinical Outcomes 
 
Hernia recurrence 
 
Our outcomes of primary interest were; hernia recurrence, the post-operative 
recurrence rates, the timing of recurrence, the definitions for VH recurrence 
used, and the test method(s) used to diagnose recurrence (for example clinical 
examination, CT scan, US scan) were recorded. These data were analysed to 
investigate whether the method used to detect recurrence influenced recurrence 
rate. As we were aware of no generally accepted imaging definition of VH 
recurrence, we anticipated considerable inter-observer variability for reporting 
recurrence.  
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We did not pre-specify the definition of post-operative hernia recurrence. We did 
not restrict by timing of recurrence, the definitions for VH recurrence used, or 
the test method(s) used to diagnose recurrence.  
 
Secondary outcomes 
 
Post-operative complications 
 
All post-operative complications described were recorded. Complications were 
grouped into intraoperative, early postoperative, late post-operative, and 
general or standardised outcomes. Early postoperative complications were sub-
grouped into local wound complications (wound infection, seroma formation, 
wound dehiscence, skin necrosis) and systemic complications (hospital acquired 
pneumonia, myocardial infarction, pulmonary embolism). Early post-operative 
complications were defined as those occurring within 30 days of surgery and late 
post-operative complications as those occurring thereafter. Late complications 
were extracted for the timespan presented in the paper.  
 
Standardised outcomes 
 
Where reported, we recorded all standardised post-operative outcome measures 
used. We anticipated that RCTs would use a variety of outcome measures such as 
length of hospital stay, 30-day re-operation rate and 30-day re-admission rate. If 
trial complications were measured using a standardised post-operative 
complication scale, the value was recorded.  
 
Patient reported outcome measures 
 
We foresaw that some trials may use standardised patient reported outcome 
measures (PROMs) to measure operative success. These may include visual 
analogue scales for pain or overall health status. They may also report the time 
to first bowel movement or the time taken to return to normal activities. All such 
outcomes were recorded, along with the timing of the assessment. 
 
Results 
 
Search results 
 
Our initial search retrieved 15771 results (fig 1.). After applying search filters 
[studies published between 1st January 1995 to 31st March 2016, human trials 
only, participants aged ≥19, studies written in English], we excluded 9286 
studies, resulting in 6485 papers for our initial review. After screening the 
citation titles, we ultimately categorised 874 studies as ‘definitely possible’ or 
‘uncertain’. This fell to 174 comparative studies after title and abstract screening. 
The full text of all 174 articles was assessed for details of study methodology. 
This identified 31 RCTs included in the present systematic review.  
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Figure 1. PRISMA diagram showing selection of RCTs for this review 
 
 
Study demographics 
 
Study demographics and design characteristics are shown in Table 1. The 31 
RCTs included 3,367 patients with a mean of 109 patients, range 24 to 337. One 
study[28] appears twice since it divided patients into simple and complex hernia 
groups, creating two individual trials (suture vs mesh repair and prosthetic mesh 
vs auto-dermal graft repair). Five RCTs were carried out in both the 
Netherlands[29–33] and Spain[34–38]. Thirteen RCTs were multi-centre and 18 
were single centre. Over the past 20 years the number of RCTs performed 
increased, with 8 published between 1995 to 2005 versus 23 published from 
2005 to 2016. There were 3 groups where RCTs compared the same 
Records	identified	through	
database	screening	
n	=	15771
Citation	title	screening:	studies	‘clearly	
unsuitable’	excluded n	=	5611	
Full	text	articles	excluded	n	=	143
• Non-randomised	design	n	=	134
• Emergency	hernia	repairs	included					n	=	2
• No	English	translation	n	=	3
• Protocol	papers	n	=	2
• Incorrect	study	design	n	=	2
Citation	title	&	abstract	screening:	studies	
‘clearly	unsuitable’	excluded	n=	700
Filters	applied	and	duplicates	
removed
n	=	6485
Studies	‘uncertain’	or	‘definitely	
possible’	remain
n	=	874
Full	text	comparative	studies	
assessed	for	eligibility
n	=	174
Randomised	controlled	trials	
included	in	qualitative	synthesis	
n	=		31
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interventions: Eleven studies compared laparoscopic versus open repair; 5 
studies[28,30,36,39,40] compared suture versus mesh repair and 3 
studies[37,41,42] compared tack versus suture mesh fixation in laparoscopic VH 
repair.  
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Table 1. Demographic and characteristics of the 31 RCTs included in the 
Systematic Review. 
 
Included Studies - Demographics 
 Characteristic Subgroup No. of RCTs 
   -Country of Publication Netherlands[29–33] Spain[34–38] 5 
 
India[41–43] Eygpt[44–46] 3 
 
Pakistan[40],[47] Turkey[39],[48] Italy[49,50]Germany [28],[51] 2 
 
Sweden[52] USA[53] Australia(54) Lithuania[55] France[56] 
Belgium[57] Denmark[58] 1 
-Multi vs Single-centre Multi centre[28-30],[32-34],[40],[49],[51-53],[57-58] 13 
 
Single centre[31],[35-39],[41-46],[48-50],[54-56] 18 
-Year of Publication 1995-2005[28],[30],[32],[35-36],[39],[46] 7 
 
2006-2016[29],[31],[33-34],[37-38],[40-45],[47-58] 24 
Included Studies 
  Characteristic Subgroup No. of RCTs 
-Trial Groups Laparoscopic vs. Open[29],[34-35],[43],[47-50],[52-54] 11 
 
Open mesh vs. suture[28],[30],[36],[39-40] 5 
 
Laparoscopic mesh fixation; Tacks vs. Sutures[31],[37],[41-42] 3 
 
 Open VH repair:  
 
 
Onlay vs. Sublay[44],[55] 2 
 
Light weight vs. Heavy weight mesh[32] 1 
 
Medium weight vs. Medium weight mesh[51] 1 
 
Autograft vs. Prosthetic mesh*[28*] 1 
 
Component separation vs. Prosthetic mesh[33] 1 
 
Onlay vs. Underlay[45] 1 
 
Intraperitoneal vs. Onlay [bridging][46] 1 
 
Ventralex patch vs Biomesh composite mesh[56] 1 
 
 Laparoscopic VH repair: 
  Double crown tack vs. suture and tack mesh fixation[31],[57] 2 
 Double crown tack vs. fibrin sealant mesh fixation[58] 1 
 
Light weight mesh vs. Medium weight mesh[38] 1 
 
Total 32 
 
*Large hernias from Korenkov et al. (a suture vs. mesh RCT) were 
analysed as a separate category. This makes this total 32 rather than 
31. 
 
-Hernia type Primary hernias only[36],[39-40],[44-45],[47] 6 
 Incisional hernias only[28-30],[32-34],[38],[46],[49-53],[55] 14 
 Primary and incisional hernias[31],[35],[37],[41-43],[48],[54],[56-58] 11 
-Primary outcomes Hernia recurrence[28],[49],[54],[56] 4 
 
Quality of life/ Health questionnaires[32],[34],[51-52] 4 
 
Pain [measured using visual analogue scores][29],[31],[57],[58] 4 
 
Pain and hernia recurrence [two primary outcomes][38] 1 
 
Mesh shrinkage[37] 1 
 
Total complications rates[53] 1 
 
Unclear[30],[33],[35-36],[39-48],[50],[55] 16 
-Risk of Bias: Cochrane 
Collaboration’s tool 
High risk of bias[28-50],[52-58] 30 
 Low risk of bias[51] 1 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias 
item presented as percentages across all included studies. 
 
 
Risk of bias and study design 
 
Thirty RCTs were assessed as at high risk of bias with just one[51] considered at 
low risk. Figure 2 shows that this high level of bias is mostly due to the failed 
blinding of trial participants, personnel (surgeons) and outpatient assessors. 
Only two trials[32],[51] achieved blinding for both these criteria.  
 
Hernia morphology 
 
Twenty-three of 30 (76.6%) RCTs used hernia dimensions as an inclusion 
criteria and one RCT[28] divided hernias into simple and complex categories 
using a 10cm defect width cutpoint. Seven trials had no selection criteria that 
used hernia dimension. The exact nature of dimension inclusion criteria varied 
across trials, ranging from hernias with a width of less than 4cm[39], to hernias 
with a width of greater than 10cm[28,46]. Fourteen trials (45.2%) recorded the 
average defect surface area, which ranged from 3.4cm2 to 141.2cm2, with a mean 
of 43.1cm2. Eleven trials (35.5%) recorded the average or median hernia width 
within each comparison group, which ranged from 3.6cm to 17cm with a mean of 
7.5cm. None of the RCTs reported loss of domain or used loss of domain for 
patient selection (Table 2.). 
 
As anticipated, no RCT recorded either VHWG grade or CDC wound classification 
of included hernias. Indeed, no RCT used a VH grading scale of any description. 
Six trials (19.3%) included primary VHs only, 14 trials (45.2%) included 
incisional hernias only, and 11 trials (35.5%) included both primary and 
incisional hernias. Ten of these 11 trials, including both primary and incisional 
VHs, reported the proportion of primary to incisional hernias, with a mean of 32 
primary to 41 incisional hernias (range 31:7[58] to 18:65[57]). Seven of the 25 
trials (28%) analysing incisional hernias included the ratio of primary incisional 
hernias to recurrent incisional hernias (mean of 84.1 primary to 28.3 incisional 
hernias, range 160:3[49] to 24:30[28]). Only two trials [30,47] reported the 
number of patients with previous ventral wound infection. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 11 
Table 2. Summarising the hernia morphology data reported. 
Hernia dimension No. of RCTs reporting variable 
Average hernia defect surface area 14[30-31],[35],[37-38],[41],[43],[50],[52-57] 
Average hernia defect width 11[28,29],[32-34],[38],[40],[44],[49-50],[52] 
Loss of Domain 0 
 
Pre-operative patient characteristics and co-morbidities 
 
Table 3 summarises the patient characteristics and comorbidities reported.  
The pre-operative patient characteristics and comorbidities reported differed 
between trials. While many reported basic patient demographics of age, gender 
and BMI, few went beyond this to report patient comorbidities, including 
smoking status, diabetic status and steroid use.  
 
Table 3. Preoperative patient characteristics and comorbidities reported.  
Patient characteristic/comorbidities No. of RCTs reporting variable 
Age [mean] 30[28-39],[41-58] 
Gender [male/female ratio] 29[28-39],[41-50],[52-58] 
Obesity [as a ratio >/< 35 or mean [SD]] 23[28-34],[37-38],[41-45],[48-50],[51-53],[55-58] 
No. patients ASA 3 10[29],[31],[36-37],[39],[45],[49],[51-53] 
COPD 8[28],[34],[38],[43],[45],[51-53] 
Smoking status 8[28],[30],[45],[51-53],[56-57] 
No. patients with Diabetes 7[34],[38],[44],[51-53],[56] 
No. patients ASA 1 7[29],[31],[45],[49],[51-53] 
No. patients ASA 2 7[29],[31],[45],[49],[51-53] 
SF-36 QoL questionnaire[59] 3[32],[51],[52] 
No. patients using steroids 3[28],[51],[53] 
No. of arteriopaths [IHD/PVD/CVA] 3[28],[44],[52] 
No. patients ASA 4 3[29],[49],[51] 
Average ASA score 2[34],[55] 
Liver cirrhosis / Childs-Pugh A 1[44] 
SF-12 QoL questionnaire[59] 1[56] 
 
Intra-operative variables 
 
Table 4 shows that intraoperative variables were reported with increased 
frequency compared to pre-operative variables and patient comorbidities. Mode 
of surgery, type of mesh implanted (prosthetic, composite, biosynthetic or 
biologic) and anatomical layer were recorded in all 31 RCTs. Operation duration, 
intra-operative blood loss and the experience of the principal operating surgeon 
were all reported less frequently. 
 
Table 4. Intra-operative variables reported.  
Intra-operative variable No. of RCTs reporting variable 
Mode of Surgery [laparoscopic/open] 31[28-58] 
Category of mesh used 31[28-58] 
Anatomical layer of mesh placement 31[28-58] 
Duration of operation 27[28-31],[33-45],[48-50],[52-58] 
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Experience of the principal surgeon 14[29],[31],[33-34],[36],[46-47],[49],[52-55],[57-58] 
Intra-operative blood loss 3[29],[33],[43] 
 
Clinical outcomes 
 
Sixty-four different clinical outcomes were reported overall, with little 
consistency between trials, even when reporting similar intervention groups and 
primary outcomes. Indeed, 16 (51.6%) RCTs stated no primary outcome 
explicitly (Table 1). Of the 15 RCTs (48.4%) stating a primary outcome; 
4[28,49,54,56] used hernia recurrence and 4[32,34,51,52] employed quality of 
life. Three trials[32],[51,52] used the SF-36 questionnaire[59] and 1 trial[34] 
used the EQ-5D questionnaire[60]. Four trials[29,31,57,58] used pain as their 
primary outcome, assessed via visual analogue scales (VASs). One trial stated 
both pain and recurrence as two separate primary outcomes, with no statistical 
accounting for co-primary outcomes[38]. The remaining two trials used mesh 
shrinkage[37] or standardised complication rates[53] as their primary outcomes 
respectively. Multiple different primary outcomes led to many different clinical 
and patient reported outcomes (as shown in online resource 2).  
 
Length of follow-up was reported in all studies and averaged 24.5 months (range 
1 month to 64 months). Fifteen of 31 (48%) trials had follow-up of at least 24 
months. One trial[52] did not report hernia recurrence rate. Of the 30 trials 
reporting hernia recurrence, 1 RCT[36] reported recurrence at 5 years post 
repair, 4 RCTs[29-30],[41],[56] reported recurrence at 3 years, 15 RCTs at 2 
years, 13 RCTs at 1 year, 5 RCTs[37],[41],[43],[50-51] at 6 months and 1 
RCT[34] at 3 months. Six (20%) of 30 RCTs defined recurrence: definitions are 
shown in table 5. Only three trials used the same definition. Eight (29%) of 30 
trials did not specify the method used to detect recurrence. Twelve trials (43%) 
used clinical examination alone to detect recurrence. Ten (33%) trials used 
imaging if recurrence was in doubt, or to confirm a recurrence suspected 
clinically. Five (50%) of these 10 trials[29,31,33,43,57] used either CT or USS to 
detect recurrence, 3 (30%) trials[30,42,58] used USS alone and 2 (20%) 
trials[38,46] used CT alone. Recurrence rates increased when imaging was used. 
Trials using clinical examination had a 4% median recurrence rate whereas trials 
using USS or CT, USS alone, or CT alone had median recurrence rates of 7%, 9% 
and 7% respectively. Trials that did not specify test methods for recurrence had 
a mean re-herniation rate of 7%. The method used to detect hernia recurrence 
did not depend on the size or type of hernia included in the trial (as shown in 
online resource 3). Patient reported outcomes used the SF-36[59], SF-12[59], 
EQ-5D[60], and GIQL[62] questionnaires as well as VASs, to assess pain and 
overall health status. These were also carried out at varying time intervals. The 
Calvien-Dindo[61] scale for post-operative complications was used in 9 of the 
trials to classify complication severity. 
 
Table 5. Six definitions of hernia recurrence encountered in the systematic 
review. 
Reference: Definition 
Arroyo et al.[36] 
(2001) 
‘the presence of a defect on the central part of the midline aponeurosis 
around the umbilicus, where the operation had been performed 
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Bensaadi et al.[56] 
(2014) 
Lal et al.[40] 
(2012) 
previously.’ 
‘a defect of the midline aponeurosis around the umbilicus at the site 
where the operation was performed.’ 
‘the presence of a defect on the central part of the midline aponeurosis 
where the operation had been performed previously.’ 
Luijendijk et al.[30] 
(2000) 
‘any fascial defect that was palable or detected by ultrasound 
examination and was located within 7cm of the site of hernia repair.’ 
Pring et al.[54] 
(2008) 
‘a clinically detectable defect, associated with the protrusion of viscera 
on straining’. 
Muysoms et al.[57] 
(2013) 
‘Patients were considered free from recurrence if at clinical 
examination, no hernia was felt in an upright position during valsalva 
manoeuver.’ 
 
Discussion 
 
This systematic review has analysed the reported perioperative variables and 
postoperative outcomes from randomised controlled trials of elective VH repair, 
performed over the last twenty years. Important findings include the general 
absence of: a standardised pre-operative patient variable dataset; a universally 
accepted definition of recurrence; standardised test methods to detect 
recurrence; standardised assessment times for the key primary and secondary 
outcomes, and standardised evaluation tools for post-operative pain and quality 
of life. This lack of standardisation limits the validity of trial comparisons made 
by meta-analyses and comparison of trials by practicing surgeons. Our review 
provides evidence-based justification for urgent investment in a core 
perioperative and clinical outcome dataset applicable to trials of VH surgery. 
This should be developed and validated with key stakeholders to improve the 
quality of outcome reporting in this rapidly developing field. A group such as 
COMET needs identification and encouragement to help develop and endorse 
this work[63]. 
 
As VH research evolves, academics are searching increasingly for outcome 
predictors. Potentially reliable predictors can be identified from the primary 
literature only when they are reported.  Our review has found that randomised 
controlled trials are focusing on surgical technique and failing to report variables 
that would normally be regarded as important predictors. For example, many 
pre-operative patient comorbidities and, in particular, measures of hernia 
morphology (e.g. hernia width and area) were omitted from most reports. Loss 
of domain was not reported by any trial. Because current evidence is 
contradictory, with some studies suggesting that hernia width does correlate 
with recurrence[64] whereas others do not[65,66], future trials need to report 
apparently important predictors to facilitate subsequent analysis. Investigators 
should also grade hernias using appropriate scales, for example the VHWG 
scale[17] and the CDC wound classification scale[27] as these scales themselves 
may prove to be outcome predictors. Our review demonstrates that a trial 
dataset with multiple pre-operative patient variables (diabetes, COPD, BMI, 
hernia grade etc), including pre-operative CT scan dimensions (hernia defect 
area, hernia width, loss of domain etc) and intra-operative variables (operation 
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time, anatomical plane of mesh insertion, reconstructive technique etc) is 
required. 
 
While 8 of the 30 trials (26.7%) reporting hernia recurrence didn’t even define 
how recurrence was detected, the remaining trials used differing recurrence 
detection methods ranging from undefined clinical examination to undefined 
imaging methods. This introduces bias depending on the differing examination 
and imaging methods used. There was much variation in the timing of 
assessment for hernia recurrence. This observed lack of consensus regarding 
assessment timing, test methods for recurrence, and definitions of recurrence 
limits data availability and consistency, and impairs meta-analysis. To achieve 
standardisation a clear definition of VH recurrence is required. Imaging is likely 
the most precise method with which to determine recurrence, but a radiological 
definition of recurrence is required that incorporates measures of clinically 
important and unimportant reherniation. Currently, there is considerable 
variability in recurrence reporting for CT scans[67]. Our review suggests that the 
use of imaging does increase reported recurrence rates, which would be 
anticipated since subclinical recurrences will be identified.  
 
RCT dataset designers should also consult the recommendations made by 
Muysoms et al. following a consensus meeting in Palmero, Italy in 2012[68]. This 
work gives detailed advice on how to carry out statistically sound research 
(interventional studies, observational studies, systematic review, and meta-
analysis) in abdominal wall repair. Of particular relevance, this article advises 
using the EuraHS definition for hernia recurrence[69]; “a protrusion of the 
contents of the abdominal cavity or preperitoneal fat through a defect in the 
abdominal wall at the site of a previous repair of an abdominal wall hernia”, which 
we support, although (as stated above) a future definition of recurrence that 
includes radiological detection maybe more accurate but requires development. 
Muysoms et al. recommend using the EHS hernias classifications scales and 
measuring post-operative complications using the Clavien-Dindo classification 
system but do not define or list any other peri-operative or post-operative 
outcome variables that sound be measured. Importantly, they do allow for 
variability in the method used for recurrence detection and the time to 
outpatient assessment, which we feel this should be standardised, especially in 
RCTs. To standardise trial outcomes, a dataset with clear definitions and follow 
up assessment times is warranted.  
 
A standardised dataset should include tools to assess chronic pain and quality of 
life (QoL). When comparing different surgical techniques, chronic pain and QoL 
are important patient-centred endpoints, as patients frequently place more 
emphasis on these outcomes than the operative surgeon. In this review, simple 
visual analogue scales were used commonly to assess pain. However, these 
analogue scales, and the timings of assessment were not standardised. A future 
dataset must standardise pain assessment. QoL was measured using many 
different questionnaires (SF-36[59], SF-12[59], EuroQoL[60]  and GIQL[62]). 
These questionnaires are commonly used and they allow for health economic 
analysis across different disease states. However, they are not disease specific, 
and may miss important patient reported outcomes specific to hernia surgery. 
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Due to the unique set of complications arising from VH surgery, the importance 
of chronic pain and QoL, a hernia-specific patient reported outcome assessment 
tool, such as the Carolinas Comfort Scale[70] or the EuraHS-QoL 
questionnaire[69], should be used.  
 
When constructing a VH perioperative variable and postoperative outcome 
dataset for randomised control trials, workers should also consult the VH 
databases currently being used in America[71], Europe[69], Denmark[72] and 
Spain[73]. These databases collect data prospectively from large cohorts of 
patients and will generate sizeable observational studies. These databases have 
been constructed by VH experts with multiple peri-operative and post-operative 
data-points, many of which should be included in an RCT dataset. 
 
As well as focusing on standardised definitions and datasets, academic surgeons 
carrying out RCTs should make concerted efforts to reduce trial bias. Thirty of 
the 31 included trials were assessed as at high risk of bias. Many of the included 
trials performed poorly in 3 out of the 7 domains of the Cochrane Collaboration’s 
tool for risk of bias[26]. Many trials failed to specify how participant group 
allocation was concealed, failed to blind participant and surgeon from the 
allocated treatment, and there was no blinding in the outpatient assessment 
clinic. Traditionally, surgical trials are usually at high risk of bias due to the 
impossibility of blinding the primary surgeon. However, if visible skin changes to 
the participant do not differ between the treatment groups [e.g. open VH repair 
with onlay vs. sublay mesh], it is possible to blind both the participant and an 
independent assessor. In addition, concealment of treatment allocation should 
follow the standards set by the Cochrane Collaboration. In surgery, the allocated 
treatment should only be revealed to an independent surgeon after the 
participant is under general anaesthetic and after the participant has been 
consented to take part in the trial and both possible treatments.   
 
Further bias can arise in RCTs due to commercial funding and readers should be 
aware of this. We accept there are difficulties in achieving non-commercial 
funding for RCTs in hernia research and that without proper funding scrupulous 
methodology can be challenging due to the high work load. Eight out of 31 one of 
the trials received commercial funding[31,32],[37],[51],[54],[56–58], one trial 
received non-commercial funding[53] and one trial received both commercial 
and non-commercial funding[52]. In the remaining 21 trials the funding method 
was not specified. The practical difficulty of obtaining non-commercial funding 
can only be addressed by researchers, who whilst applying for funding must 
clearly explain the technical difficulties faced by reconstructive surgeons and the 
high prevalence of morbidity suffered by patients after hernia repair; namely 
chronic pain and recurrence. If researchers face difficulties with funding or 
carryout research with commercial funding, little can be done apart from 
carrying out research to highest possible standards. We note that any data is 
better than no data, as supported by Lilford et al[74].  
 
Conclusion 
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So far systematic reviews of elective VH RCTs have focused on comparing the 
outcomes of open versus laparoscopic VH repair[75],[76],[77]. This review is the 
first to assesses the methodology of VH RCTs. The results show that the 
perioperative variables and postoperative outcomes reported by RCTs of VH 
repair lack definition and consistency. To solve this, a defined minimum dataset 
of variables and outcomes is required. Since operative success is determined by 
the presence or absence of hernia recurrence, recurrence is therefore the prime 
outcome and requires standard clinical and radiological definitions, together 
with a minimum period of follow-up. For a clinical definition, we recommend 
using the European definition for hernia recurrence[69], and that a radiological 
definition requires development. Such measures will standardise and therefore 
improve outcome reporting in this rapidly expanding and important field, 
increasing data homogeneity and the value of subsequent meta-analysis.  
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Figure 1. PRISMA diagram showing selection of RCTs for this review 
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possible’	remain
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n	=		31
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item 
presented as percentages across all included studies. 
 
Figure Click here to download Figure Figure2.docx 
Table 1. Demographic and characteristics of the 31 RCTs included in the Systematic 
Review. 
Included Studies - Demographics  
Characteristic Subgroup No. of RCTs 
   
-Country of Publication Netherlands[29–33] Spain[34–38] 5 
 India[41–43] Eygpt[44–46] 3 
 Pakistan[40],[47] Turkey[39],[48] Italy[49,50]Germany [28],[51] 2 
 
Sweden[52] USA[53] Australia[54] Lithuania[55] France[56] 
Belgium[57] Denmark[58] 1 
-Multi vs Single-centre Multi centre[28-30],[32-34],[40],[49],[51-53],[57-58] 13 
 Single centre[31],[35-39],[41-46],[48-50],[54-56] 18 
-Year of Publication 1995-2005[28],[30],[32],[35-36],[39],[46] 7 
 2006-2016[29],[31],[33-34],[37-38],[40-45],[47-58] 24 
Included Studies   
Characteristic Subgroup No. of RCTs 
-Trial Groups Laparoscopic vs. Open[29],[34-35],[43],[47-50],[52-54] 11 
 Open mesh vs. suture[28],[30],[36],[39-40] 5 
 Laparoscopic mesh fixation; Tacks vs. Sutures[31],[37],[41-42] 3 
  Open ventral hernia repair:   
 Onlay vs. Sublay[44],[55] 2 
 Light weight vs. Heavy weight mesh[32] 1 
 Medium weight vs. Medium weight mesh[51] 1 
 Autograft vs. Prosthetic mesh*[28*] 1 
 Component separation vs. Prosthetic mesh[33] 1 
 Onlay vs. Underlay[45] 1 
 Intraperitoneal vs. Onlay [bridging][46] 1 
 Ventralex patch vs Biomesh composite mesh[56] 1 
  Laparoscopic ventral hernia repair:  
 Double crown tack vs. suture and tack mesh fixation[31],[57] 2 
 Double crown tack vs. fibrin sealant mesh fixation[58] 1 
 Light weight mesh vs. Medium weight mesh[38] 1 
 Total 32 
 
*Large hernias from Korenkov et al. (a suture vs. mesh RCT) were 
analysed as a separate category. This makes this total 32 rather than 31. 
 
-Hernia type Primary hernias only[36],[39-40],[44-45],[47] 6 
 Incisional hernias only[28-30],[32-34],[38],[46],[49-53],[55] 14 
 Primary and incisional hernias[31],[35],[37],[41-43],[48],[54],[56-58] 11 
-Primary outcomes Hernia recurrence[28],[49],[54],[56] 4 
 Quality of life/ Health questionnaires[32],[34],[51-52], 4 
 Pain [measured using visual analogue scores][29],[31],[57],[58] 4 
 Pain and hernia recurrence [two primary outcomes][38] 1 
 Mesh shrinkage[37] 1 
 Total complications rates[53] 1 
 Unclear[30],[33],[35-36],[39-48],[50],[55] 16 
Table Click here to download Table Table 1.docx 
 -Risk of Bias: Cochrane 
Collaboration’s tool 
High risk of bias[28-50],[52-58] 30 
 Low risk of bias[51] 1 
Table 2. Summarising the hernia morphology data reported. 
Hernia dimension No. of RCTs reporting variable 
Average hernia defect surface area 14[30-31],[35],[37-38],[41],[43],[50],[52-57] 
Average hernia defect width 11[28,29],[32-34],[38],[40],[44],[49-50],[52] 
Loss of Domain 0 
 
Table Click here to download Table Table 2.docx 
Table 3. Preoperative patient characteristics and comorbidities reported. 
Patient characteristic/comorbidities No. of RCTs reporting variable 
Age [mean] 30[28-39],[41-58] 
Gender [male/female ratio] 29[28-39],[41-50],[52-58] 
Obesity [as a ratio >/< 35 or mean [SD]] 23[28-34],[37-38],[41-45],[48-50],[51-53],[55-58] 
No. patients ASA 3 10[29],[31],[36-37],[39],[45],[49],[51-53] 
COPD 8[28],[34],[38],[43],[45],[51-53] 
Smoking status 8[28],[30],[45],[51-53],[56-57] 
No. patients with Diabetes 7[34],[38],[44],[51-53],[56] 
No. patients ASA 1 7[29],[31],[45],[49],[51-53] 
No. patients ASA 2 7[29],[31],[45],[49],[51-53] 
SF-36 QoL questionnaire[59] 3[32],[51],[52] 
No. patients using steroids 3[28],[51],[53] 
No. of arteriopaths [IHD/PVD/CVA] 3[28],[44],[52] 
No. patients ASA 4 3[29],[49],[51] 
Average ASA score 2[34],[55] 
Liver cirrhosis / Childs-Pugh A 1[44] 
SF-12 QoL questionnaire[59] 1[56] 
 
Table Click here to download Table Table 3.docx 
Table 4. Intra-operative variables reported. 
Intra-operative variable No. of RCTs reporting variable 
Mode of Surgery [laparoscopic/open] 31[28-58] 
Category of mesh used 31[28-58] 
Anatomical layer of mesh placement 31[28-58] 
Duration of operation 27[28-31],[33-45],[48-50],[52-58] 
Experience of the principal surgeon 14[29],[31],[33-34],[36],[46-47],[49],[52-55],[57-58] 
Intra-operative blood loss 3[29],[33],[43] 
 
Table Click here to download Table Table 4.docx 
Table 5. Six definitions of hernia recurrence encountered in the systematic review. 
Reference: Definition 
Arroyo et al.[36] 
 
 
Bensaadi et al.[56] 
 
Lal et al.[40] 
‘the presence of a defect on the central part of the midline aponeurosis 
around the umbilicus, where the operation had been performed 
previously.’ 
‘a defect of the midline aponeurosis around the umbilicus at the site 
where the operation was performed.’ 
‘the presence of a defect on the central part of the midline aponeurosis 
where the operation had been performed previously.’ 
Luijendijk et al.[30] ‘any fascial defect that was palable or detected by ultrasound 
examination and was located within 7cm of the site of hernia repair.’ 
Pring et al.[54] ‘a clinically detectable defect, associated with the protrusion of viscera 
on straining’. 
Muysoms et al.[57] ‘Patients were considered free from recurrence if at clinical 
examination, no hernia was felt in an upright position during valsalva 
manoeuver.’ 
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